Kilitch Drugs (India) Bilan de santé
Santé financière contrôle des critères 5/6
Kilitch Drugs (India) possède un total de capitaux propres de ₹1.9B et une dette totale de ₹324.1M, ce qui porte son ratio d'endettement à 17.2%. Son actif total et son passif total sont ₹2.6B et de ₹709.5M. L'EBIT de Kilitch Drugs (India) est ₹154.0M ce qui fait que son ratio de couverture des intérêts 3.4. Elle dispose de liquidités et de placements à court terme de ₹588.5M.
Informations clés
17.2%
Ratio d'endettement
₹324.12m
Dette
| Ratio de couverture des intérêts | 3.4x |
| Argent liquide | ₹588.52m |
| Fonds propres | ₹1.88b |
| Total du passif | ₹709.50m |
| Total des actifs | ₹2.59b |
Mises à jour récentes de la santé financière
Here's Why Kilitch Drugs (India) (NSE:KILITCH) Can Manage Its Debt Responsibly
Mar 05
These 4 Measures Indicate That Kilitch Drugs (India) (NSE:KILITCH) Is Using Debt Reasonably Well
Sep 08Kilitch Drugs (India) (NSE:KILITCH) Could Easily Take On More Debt
Jul 06These 4 Measures Indicate That Kilitch Drugs (India) (NSE:KILITCH) Is Using Debt Reasonably Well
Dec 17Is Kilitch Drugs (India) (NSE:KILITCH) Using Too Much Debt?
Mar 21Is Kilitch Drugs (India) (NSE:KILITCH) Weighed On By Its Debt Load?
Dec 03
Recent updates
Kilitch Drugs (India) Limited (NSE:KILITCH) Not Flying Under The Radar
Jul 23Here's Why Kilitch Drugs (India) (NSE:KILITCH) Can Manage Its Debt Responsibly
Mar 05Kilitch Drugs (India) Limited (NSE:KILITCH) Looks Just Right With A 26% Price Jump
Feb 02We Ran A Stock Scan For Earnings Growth And Kilitch Drugs (India) (NSE:KILITCH) Passed With Ease
Jan 30Investors Shouldn't Be Too Comfortable With Kilitch Drugs (India)'s (NSE:KILITCH) Earnings
Nov 17Shareholders Would Not Be Objecting To Kilitch Drugs (India) Limited's (NSE:KILITCH) CEO Compensation And Here's Why
Sep 23These 4 Measures Indicate That Kilitch Drugs (India) (NSE:KILITCH) Is Using Debt Reasonably Well
Sep 08Here's Why Kilitch Drugs (India) (NSE:KILITCH) Has Caught The Eye Of Investors
May 05Kilitch Drugs (India) (NSE:KILITCH) Could Easily Take On More Debt
Jul 06Here's Why I Think Kilitch Drugs (India) (NSE:KILITCH) Might Deserve Your Attention Today
Apr 08These 4 Measures Indicate That Kilitch Drugs (India) (NSE:KILITCH) Is Using Debt Reasonably Well
Dec 17Is Kilitch Drugs (India) (NSE:KILITCH) Using Too Much Debt?
Mar 21Should Weakness in Kilitch Drugs (India) Limited's (NSE:KILITCH) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Feb 13Is Kilitch Drugs (India) (NSE:KILITCH) Weighed On By Its Debt Load?
Dec 03Does Kilitch Drugs (India) Limited (NSE:KILITCH) Have A Place In Your Dividend Stock Portfolio?
Aug 20Should Weakness in Kilitch Drugs (India) Limited's (NSE:KILITCH) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Jul 16Analyse de la situation financière
Passif à court terme: Les actifs à court terme de KILITCH ( ₹1.5B ) dépassent ses passifs à court terme ( ₹707.8M ).
Passif à long terme: Les actifs à court terme de KILITCH ( ₹1.5B ) dépassent ses passifs à long terme ( ₹1.7M ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: KILITCH dispose de plus de liquidités que de sa dette totale.
Réduire la dette: Le ratio d'endettement de KILITCH est passé de 10.9% à 17.2% au cours des 5 dernières années.
Couverture de la dette: La dette de KILITCH est bien couverte par le flux de trésorerie opérationnel ( 64.9% ).
Couverture des intérêts: Les paiements d'intérêts de KILITCH sur sa dette sont bien couverts par l'EBIT ( 3.4 x couverture).